Bayer faces second trial over alleged Roundup cancer risk
Source: Reuters
BUSINESS NEWS FEBRUARY 24, 2019 / 8:03 AM / UPDATED 36 MINUTES AGO
Bayer faces second trial over alleged Roundup cancer risk
Tina Bellon
3 MIN READ
(Reuters) - Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company’s share price was rocked by a $289 million verdict in California state court.
A lawsuit by California resident Edwin Hardeman against the company was scheduled to begin on Monday in federal rather than state court. The trial is also a test case for a larger litigation. More than 760 of the 9,300 Roundup cases nationwide are consolidated in the federal court in San Francisco that is hearing Hardeman’s case.
Bayer denies all allegations that Roundup or glyphosate cause cancer, saying decades of independent studies have shown the world’s most widely used weed killer to be safe for human use and noting that regulators around the world have approved the product.
Under a January ruling by U.S. District Judge Vince Chhabria, who presides over the federal litigation, jurors in Hardeman’s case will not initially hear all the evidence presented in last year’s California trial.
-snip-
Read more: https://www.reuters.com/article/us-bayer-glyphosate-lawsuit/bayer-faces-second-trial-over-alleged-roundup-cancer-risk-idUSKCN1QD0I8